US 11085022
Inflammation-targeted neutrophil granulocyte drug delivery system and use thereof
granted A61KA61K31/192A61K31/337
Quick answer
US patent 11085022 (Inflammation-targeted neutrophil granulocyte drug delivery system and use thereof) held by CHINA PHARMACEUTICAL UNIVERSITY expires Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CHINA PHARMACEUTICAL UNIVERSITY
- Grant date
- Tue Aug 10 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/192, A61K31/337, A61K31/5383, A61K31/7105